Wallemacq PE - Search Results

1

Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin.

Delattre IK, Musuamba FT, Verbeeck RK, Dugernier T, Spapen H, Laterre PF, Wittebole X, Cumps J, Taccone FS, Vincent JL, Jacobs F, Wallemacq PE. Delattre IK, et al. Among authors: wallemacq pe. Clin Biochem. 2010 Apr;43(6):589-98. doi: 10.1016/j.clinbiochem.2009.12.007. Epub 2009 Dec 28. Clin Biochem. 2010. PMID: 20036226

2

Isolation and mass spectrometric identification of five metabolites of FK-506, a novel macrolide immunosuppressive agent, from human plasma.

Lhoëst G, Wallemacq P, Verbeeck R. Lhoëst G, et al. Pharm Acta Helv. 1991;66(11):302-6. Pharm Acta Helv. 1991. PMID: 1722046 No abstract available.

3

Computerized approach to monitoring aminoglycosides.

Leal T, Parez JJ, Vanbinst R, Wallemacq PE. Leal T, et al. Among authors: wallemacq pe. Clin Chem. 1991 Aug;37(8):1415-9. Clin Chem. 1991. PMID: 1868604

4

Excretion of tacrolimus glucuronides in human bile.

Firdaous I, Verbeeck RK, Hassoun A, Langrehr JM, Wallemacq PE. Firdaous I, et al. Among authors: wallemacq pe. Eur J Drug Metab Pharmacokinet. 1997 Jul-Sep;22(3):217-21. doi: 10.1007/BF03189810. Eur J Drug Metab Pharmacokinet. 1997. PMID: 9358202

5

Isolation from pig liver microsomes, identification by electrospray tandem mass spectrometry and in vitro immunosuppressive activity of a rapamycin tris-epoxide metabolite.

Lhoëst G, Zey T, Verbeeck RK, Wallemacq P, Maton N, De Houx JP, Latinne D. Lhoëst G, et al. J Mass Spectrom. 1999 Jan;34(1):28-32. doi: 10.1002/(SICI)1096-9888(199901)34:1<28::AID-JMS747>3.0.CO;2-#. J Mass Spectrom. 1999. PMID: 10028689

6

Isolation, identification and immunosuppressive activity of SDZ-IMM-125 metabolites from human liver microsomes.

Dieden R, Verbeeck RK, Latinne D, Wallemacq P, Maton N, Lhoest GJ. Dieden R, et al. Eur J Drug Metab Pharmacokinet. 1999 Jan-Mar;24(1):83-90. doi: 10.1007/BF03190015. Eur J Drug Metab Pharmacokinet. 1999. PMID: 10412896

7

Transjugular intrahepatic portosystemic shunt after adult liver transplantation: experience in eight patients.

Lerut JP, Goffette P, Molle G, Roggen FM, Puttemans T, Brenard R, Morelli MC, Wallemacq P, Van Beers B, Laterre PF. Lerut JP, et al. Transplantation. 1999 Aug 15;68(3):379-84. doi: 10.1097/00007890-199908150-00009. Transplantation. 1999. PMID: 10459541

8

Isolation from pig liver microsomes, identification by tandem mass spectrometry and in vitro immunosuppressive activity of an SDZ-RAD 17,18,19,20,21,22-tris-epoxide.

Lhoëst GJ, Gougnard TY, Verbeeck RK, Maton N, Dehoux JP, Wallemacq P, Schüler W, Latinne D. Lhoëst GJ, et al. J Mass Spectrom. 2000 Mar;35(3):454-60. doi: 10.1002/(SICI)1096-9888(200003)35:3<454::AID-JMS959>3.0.CO;2-K. J Mass Spectrom. 2000. PMID: 10767777

9

Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients.

Wallemacq PE, Verbeeck RK. Wallemacq PE, et al. Clin Pharmacokinet. 2001;40(4):283-95. doi: 10.2165/00003088-200140040-00004. Clin Pharmacokinet. 2001. PMID: 11368293 Review.

10

In vitro immunosuppressive activity of tacrolimus dihydrodiol precursors obtained by chemical oxidation and identification of a new metabolite of SDZ-RAD by electrospray and electrospray-linked scan mass spectrometry.

Lhoëst G, Hertsens R, Verbeeck RK, Maton N, Wallemacq P, Dehoux JP, Latinne D. Lhoëst G, et al. J Mass Spectrom. 2001 Aug;36(8):889-901. doi: 10.1002/jms.190. J Mass Spectrom. 2001. PMID: 11523088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters